Effects of a combination of losartan and hydrochlorothiazide in patients with hypertension and a history of heart failure

Tokai J Exp Clin Med. 2014 Mar 20;39(1):1-4.

Abstract

Objectives: To evaluate the switching from an angiotensin receptor blocker (ARB) to a drug combination containing an ARB and a diuretic drug in terms of effects on hypertension, cardiac load, and cardiac function.

Methods: In a study conducted on 82 patients with a history of heart failure and hypertension who had been treated with an ARB but failed to reach the target blood pressure, ongoing oral ARB treatment was switched to a drug combination of losartan and hydrochlorothiazide (HCTZ). Using ambulatory blood pressure monitoring (ABPM), the variations in blood pressure and the effects on cardiac load and cardiac function were evaluated before and after treatment.

Results: Comparison of the ABPM findings before and after switching treatment showed significant improvements in mean systolic and diastolic blood pressure, improvements in systolic and diastolic blood pressure 1 hour before getting out of bed, and improvements in the plasma levels of human brain natriuretic peptide as an indicator of cardiac load.

Conclusion: The drug combination of losartan and hydrochlorothiazide showed a stronger antihypertensive effect than that of the conventional ARB and improved heart function.

MeSH terms

  • Aged
  • Angiotensin II Type 1 Receptor Blockers / therapeutic use*
  • Antihypertensive Agents / therapeutic use*
  • Biomarkers / blood
  • Blood Pressure
  • Diuretics / therapeutic use*
  • Drug Substitution
  • Drug Therapy, Combination
  • Female
  • Heart Failure / diagnosis
  • Heart Failure / drug therapy*
  • Heart Failure / physiopathology
  • Heart Function Tests
  • Humans
  • Hydrochlorothiazide / therapeutic use*
  • Hypertension / complications
  • Hypertension / diagnosis
  • Hypertension / drug therapy*
  • Hypertension / physiopathology
  • Losartan / therapeutic use*
  • Male
  • Middle Aged
  • Natriuretic Peptide, Brain / blood
  • Patient Compliance
  • Treatment Outcome

Substances

  • Angiotensin II Type 1 Receptor Blockers
  • Antihypertensive Agents
  • Biomarkers
  • Diuretics
  • Hydrochlorothiazide
  • Natriuretic Peptide, Brain
  • Losartan